Status:
UNKNOWN
Study of Pulmonary Artery Banding for the Improvement of Left Ventricular Function in Pediatric Heart Failure
Lead Sponsor:
China National Center for Cardiovascular Diseases
Collaborating Sponsors:
Peking University First Hospital
Beijing Children's Hospital
Conditions:
Heart Failure Congenital
Eligibility:
All Genders
Up to 14 years
Brief Summary
The goal of this observational study is to learn about the safety and effectiveness of pulmonary artery banding(PAB) therapy in pediatric heart failure(PHF) patients. The main questions it aims to an...
Eligibility Criteria
Inclusion
- patients younger than 14 years of age
- congenital heart failure (LVEF\<55%, or LVFS\<25%)
Exclusion
- single ventricle
- congenital heart disease without anatomical correction
- Patients with heart failure requiring ventricular assist or cardiac synchronization therapy
- Patients with severe pulmonary hypertension (pulmonary arterial pressure \>6 Wood·U)
- Patients with severe liver and kidney failure
- Patients who are allergic to related medications
- Patients with symptomatic hypotension who cannot tolerate related drugs
- Refuse to sign the informed consent or refuse to participate in this experiment
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06039553
Start Date
January 1 2022
End Date
December 31 2024
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai hospital
Beijing, Beijing Municipality, China, 100037